Dayspring compression therapy system is now FDA cleared for treatment of lymphedema and venous diseases in both upper and lower extremities.
Nonmelanoma skin cancers account for more than 75 percent of all cancers diagnosed in the United States.
“Medtech is a small world. We’re all in this together. If we can all support each other, and help the overall ecosystem, that can really lift everybody up. That’s how we all win together.”
The funding will be used to commercialize Mind.Px, a groundbreaking tool to prospectively predict patient response to expensive psoriasis biologics.
cmAssist by CureMetrix helps radiologists by identifying, marking and scoring regions of interest on screening mammograms.
Multicenter Study to Compare Outcomes of Brain Tumor Resection Surgery Accompanied by GammaTile Therapy to Surgery Followed by Stereotactic Radiotherapy
Mindera dermal biomarker patch technology generates clinically validated data to lower healthcare costs and improve patient outcomes.
This is the first time that a large-scale, phase 3 randomized controlled trial in ophthalmology was able to be replicated using a real-world data set.
“We really don’t have a good diagnostic test for bowel function and motility. Using a little patch externally and noninvasively is an exciting concept.”
Partnership allows Ambra Health and Arterys platforms to directly integrate for improved interoperability.